N
Nurix Therapeutics D
D
NRIX
16.930
USD
-0.04
(-0.24%)
مفتوح الان
حجم التداول
6,967
الربح لكل سهم
-3
العائد الربحي
-
P/E
-5
حجم السوق
1,749,626,356
العنوان: Nurix Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
